Search

Copyright of Nachrichten aus der Chemie is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In an interview with Benjamin List, winner of the 2021 Nobel Prize in Chemistry, members of the Young Chemists' Network (JCF) of the German Chemical Society (GDCh) asked him about his science, his career, and the academic system. Benjamin List, Director at the Max‐Planck‐Institut für Kohlenforschung in Germany, was awarded the Nobel Prize together with David W. C. MacMillan (Princeton University, USA) for the development of asymmetric organocatalysis. After studying chemistry at the Free University of Berlin, he received his doctorate from Goethe University in Frankfurt. He discovered the amino acid proline to be an efficient catalyst and thus co‐founded the field of organocatalysis. In 2016, he received the Gottfried Wilhelm Leibniz Prize, which is considered the most important research award in Germany. [ABSTRACT FROM AUTHOR]

Copyright of Nachrichten aus der Chemie is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Nachrichten aus der Chemie is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

It is incumbent on every individual in the research system - as it is on the system as a whole - to subject their own capabilities and limitations to critical reflection, particularly at times of increasingly rapid change in research and in the circumstances surrounding it. A statement on the occasion of the award of this year's Leibniz Prizes. [ABSTRACT FROM AUTHOR]

Announces a prize awarded by a German Science Foundation that aims to advance clinical research into chronic bleeding conditions, especially haemophilia and related diseases. Call for submission of research papers; Contact information; Awarding at the 33rd Hemophilia Symposium in Hamburg, Germany.

Comments on the funding of research prizes in Germany by the tobacco firm Philip Morris. Opinion that soul-searching and angst are typical German characteristics which seem to be lacking in this situation; How the Philip Morris award has been awarded since 1983 without attracting much controversy; Opinion that accepting a prize from this company is a possible compromise of scientific ethics.